Dr. Thomas Insel, who directed the National Institute of Psychological Well being from 2002 to 2015 and it is an advisor to and investor in Compass Pathways, a biotechnology organization managing medical trials of psilocybin, the psychoactive element of magic mushrooms, thinks these troubles say more about Lykos compared to the copyright discipline